IDEXX Laboratories (IDXX) is scheduled to report Q1 earnings on May 5, 2026. Analysts estimate EPS of $3.43 and quarterly revenue of $1.12B.

In the most recent quarter (Q4), IDEXX Laboratories reported EPS of $3.08, beating estimates of $2.93 by 0.05%. Revenue came in at $1.09B, exceeding the estimate of $1.07B by 0.02%.

IDEXX Laboratories has beaten EPS estimates in 8 consecutive quarters.

Over the last 4 quarters, IDEXX Laboratories has averaged an EPS surprise of 0.04% and a revenue surprise of 0.02%.